Congleton Jon - Insider Non-Derivative Transactions at Mineralys Therapeutics, Inc. (MLYS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 11, 2024, Congleton Jon's relationship to Mineralys Therapeutics, Inc. (MLYS) is Director,Officer (Chief Executive Officer), and currently has 911,212 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other MLYS insiders.
Data Source: SEC.
Congleton Jon - Insider Non-Derivative Transactions of MLYS Common Stock
Congleton Jon - Insider Non-Derivative Transactions at MLYS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 12, 2024 | Sell -- (Common Stock) | 15746 | 13.34 | 911212 |
| Jun 21, 2024 | Sell -- (Common Stock) | 14940 | 11.73 | 926958 |
| Jun 19, 2024 | Sell -- (Common Stock) | 16607 | 11.99 | 941898 |
| Jun 18, 2024 | Sell -- (Common Stock) | 17766 | 12.25 | 958505 |
| Jun 15, 2024 | Sell -- (Common Stock) | 16229 | 12.52 | 976271 |
| Jun 14, 2024 | Sell -- (Common Stock) | 39961 | 12.74 | 992500 |
| Jun 13, 2024 | Sell -- (Common Stock) | 16607 | 12.77 | 1032461 |
| Nov 23, 2023 | P -- (Common Stock) | 4250 | 5.97 | 1049068 |
| Sep 7, 2023 | P -- (Common Stock) | 2250 | 12.08 | 1044818 |
| Aug 18, 2023 | P -- (Common Stock) | 2250 | 12.1 | 1042568 |
| Aug 12, 2023 | P -- (Common Stock) | 2000 | 12.89 | 1040318 |